VPIM
ABBV icon

Vanguard Personalized Indexing Management’s AbbVie ABBV Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.4M Buy
305,324
+11,790
+4% +$2.62M 0.65% 20
2025
Q4 		$67.1M Buy
293,534
+9,546
+3% +$2.17M 0.65% 17
2025
Q3 		$65.8M Buy
283,988
+10,249
+4% +$2.09M 0.67% 19
2025
Q2 		$50.8M Buy
273,739
+37,680
+16% +$7M 0.57% 21
2025
Q1 		$49.5M Buy
236,059
+32,343
+16% +$6.29M 0.73% 20
2024
Q4 		$36.2M Buy
203,716
+7,030
+4% +$1.29M 0.55% 23
2024
Q3 		$38.8M Buy
196,686
+30,816
+19% +$5.75M 0.63% 21
2024
Q2 		$28M Buy
165,870
+15,302
+10% +$2.53M 0.53% 23
2024
Q1 		$27.4M Buy
150,568
+18,173
+14% +$3.13M 0.59% 21
2023
Q4 		$20.5M Sell
132,395
-4,945
-4% -$721K 0.53% 22
2023
Q3 		$20.5M Buy
137,340
+19,753
+17% +$2.9M 0.61% 24
2023
Q2 		$15.8M Sell
117,587
-6,986
-6% -$1.02M 0.49% 28
2023
Q1 		$19.2M Buy
124,573
+19,500
+19% +$2.98M 0.67% 19
2022
Q4 		$17M Buy
105,073
+8,820
+9% +$1.35M 0.7% 18
2022
Q3 		$12.9M Buy
96,253
+3,922
+4% +$563K 0.58% 21
2022
Q2 		$14.1M Buy
92,331
+18,198
+25% +$2.78M 0.66% 19
2022
Q1 		$12M Buy
74,133
+13,117
+21% +$1.91M 0.58% 19
2021
Q4 		$8.26M Buy
61,016
+16,050
+36% +$1.9M 0.49% 26
2021
Q3 		$4.85M Buy
44,966
+4,990
+12% +$570K 0.44% 32
2021
Q2 		$4.5M Buy
39,976
+10,299
+35% +$1.16M 0.47% 26
2021
Q1 		$3.21M Buy
29,677
+13,496
+83% +$1.44M 0.49% 31
2020
Q4 		$1.73M Sell
16,181
-134
-0.8% -$12.9K 0.38% 52
2020
Q3 		$1.43M Buy
16,315
+5,924
+57% +$558K 0.4% 54
2020
Q2 		$1.02M Buy
10,391
+4,242
+69% +$373K 0.46% 43
2020
Q1 		$469K Buy
+6,149
New +$524K 0.27% 99

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Personalized Indexing Management's ABBV Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its AbbVie (ABBV) stake by 4% in Q1 2026, buying an estimated $2.62M and bringing the position to 305,324 shares worth $66.4M. The position accounts for 0.65% of the portfolio, ranked #20.

Vanguard Personalized Indexing Management first reported a position in ABBV in Q1 2020 and has held it in 25 quarters since. The position peaked at $67.1M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Vanguard Personalized Indexing Management held 305,324 shares of AbbVie worth $66.4M as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 11,790 AbbVie shares in Q1 2026, an estimated $2.62M.
  • AbbVie made up 0.65% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #20 holding.
  • Vanguard Personalized Indexing Management first reported a position in AbbVie in Q1 2020 and has held it in 25 quarters since.
  • Vanguard Personalized Indexing Management's AbbVie position peaked at $67.1M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.